U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H14N2O4
Molecular Weight 226.2292
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PORPHOBILINOGEN

SMILES

NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1

InChI

InChIKey=QSHWIQZFGQKFMA-UHFFFAOYSA-N
InChI=1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16)

HIDE SMILES / InChI

Molecular Formula C10H14N2O4
Molecular Weight 226.2292
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

An acute attack may be precipitated by drugs affecting the liver, by infection and by diet. The discovery of porphobilinogen in urine is a critical value that can eliminate or reduce adverse effects from drugs or anesthetics.

Approval Year

PubMed

PubMed

TitleDatePubMed
Erythropoietin treatment in the neuropsychiatric porphyrias.
2003-12
Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
2003-11
Identification of rate-limiting steps in yeast heme biosynthesis.
2003-10-31
Renal transplantation in a case of acute intermittent porphyria.
2003-10
Gene-specific monitoring of T7-based RNA amplification by real-time quantitative PCR.
2003-09
The biology of the Ets1 proto-oncogene.
2003-08-20
Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.
2003-08-18
[An acute attack of hereditary coproporphyria concomitant with severe generalized polyneuropathy and respiratory insufficiency].
2003-08-16
A porphobilinogen deaminase (PBGD) Ran-binding protein interaction is implicated in nuclear trafficking of PBGD in differentiating glioma cells.
2003-08-14
X-ray structure of a putative reaction intermediate of 5-aminolaevulinic acid dehydratase.
2003-08-01
Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery.
2003-08
Leptospira spp. possess a complete haem biosynthetic pathway and are able to use exogenous haem sources.
2003-08
Necrotic cell death induced by delta-aminolevulinic acid in mouse astrocytes. Protective role of melatonin and other antioxidants.
2003-08
5-Aminolevulinic acid synthesis in epimastigotes of Trypanosoma cruzi.
2003-08
The porphyrias, appropriate test selection.
2003-07-15
Mechanistic studies on delta-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line.
2003-07-07
Aminolaevulinic acid-induced protoporphyrin IX pharmacokinetics in central and peripheral arteries of the rat.
2003-07
Photophysical and lasing properties of new analogs of the boron-dipyrromethene laser dye pyrromethene 567 incorporated into or covalently bounded to solid matrices of poly(methyl methacrylate).
2003-07
Measurement of urinary porphyrins and porphyrin precursors in Dutch hospital laboratories: a review of quality control over 5 years.
2003-07
Acute porphyrias in the Argentinean population: a review.
2003-06
Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation.
2003-06
Stereochemistry and mechanism of the conversion of 5-aminolaevulinic acid into porphobilinogen catalysed by porphobilinogen synthase.
2003-05-07
Acute intermittent porphyria in childhood: a population-based study.
2003-05
Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis.
2003-04-22
2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
2003-03-03
Identification and functional analysis of enzymes required for precorrin-2 dehydrogenation and metal ion insertion in the biosynthesis of sirohaem and cobalamin in Bacillus megaterium.
2003-03-01
A new synthesis of porphobilinogen analogues, inhibitors of hydroxymethylbilane synthase.
2003-01-07
Effects of continuous light exposure on antioxidant enzymes, porphyric enzymes and cellular damage in the Harderian gland of the Syrian hamster.
2003-01
Time-resolved and static-ensemble structural chemistry of hydroxymethylbilane synthase.
2003
Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
2002-12
Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics.
2002-12
The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
2002-11-29
Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
2002-11
Quantitative real-time RT-PCR using hybridization probes and imported standard curves for cytokine gene expression analysis.
2002-11
Adrenomedullin gene expression in human placental tIssue and leukocytes: a potential marker of severe tIssue hypoxia in neonates with birth asphyxia.
2002-11
The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage.
2002-11
Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
2002-11
[Nephrologists and porphyrias].
2002-10-09
Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene.
2002-10
Rat kidney porphobilinogen deaminase kinetics. Detection of enzyme-substrate complexes.
2002-10
Analysis of EF-hand-containing proteins in Arabidopsis.
2002-09-23
ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice.
2002-09-23
Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters.
2002-08-12
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
2002-08-09
5-Aminolaevulinic acid dehydratase: metals, mutants and mechanism.
2002-08
Diagnostic dilemmas in acute intermittent porphyria. A case report.
2002-07-19
Structure of porphobilinogen synthase from Pseudomonas aeruginosa in complex with 5-fluorolevulinic acid suggests a double Schiff base mechanism.
2002-07-05
Management of acute and cutaneous porphyrias.
2002-05
Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients.
2002
Porphobilinogen deaminase: accumulation and detection of tetrapyrrole intermediates using enzyme immobilization.
2002
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:55:24 GMT 2025
Edited
by admin
on Mon Mar 31 19:55:24 GMT 2025
Record UNII
74KHC72QXK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PORPHOBILINOGEN [MI]
Preferred Name English
PORPHOBILINOGEN
MI  
Common Name English
1H-PYRROLE-3-PROPANOIC ACID, 5-(AMINOMETHYL)-4-(CARBOXYMETHYL)-
Systematic Name English
3-(5-(AMINOMETHYL)-4-(CARBOXYMETHYL)-1H-PYRROL-3-YL)PROPANOIC ACID
Systematic Name English
Classification Tree Code System Code
LOINC 34356-6
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 2811-8
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
CFR 21 CFR 862.1590
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 14882-5
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 12245-7
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 2809-2
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 56483-1
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 34357-4
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 27382-1
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 2810-0
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 74441-7
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 24446-7
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 17474-8
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
LOINC 13797-6
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID4060070
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
CAS
487-90-1
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
DRUG BANK
DB02272
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
MERCK INDEX
m8991
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY Merck Index
PUBCHEM
1021
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
FDA UNII
74KHC72QXK
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-666-3
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
CHEBI
58126
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
MESH
D011162
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
WIKIPEDIA
PORPHOBILINOGEN
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY
CHEBI
17381
Created by admin on Mon Mar 31 19:55:24 GMT 2025 , Edited by admin on Mon Mar 31 19:55:24 GMT 2025
PRIMARY